Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,927 | 75 | 90.7% |
| Education | $198.00 | 2 | 9.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ViiV Healthcare Company | $419.68 | 14 | $0 (2024) |
| Gilead Sciences, Inc. | $380.18 | 14 | $0 (2024) |
| ABBVIE INC. | $331.73 | 15 | $0 (2024) |
| Shionogi Inc | $237.01 | 10 | $0 (2024) |
| Janssen Products, LP | $198.00 | 2 | $0 (2022) |
| AIMMUNE THERAPEUTICS, INC. | $146.91 | 3 | $0 (2024) |
| Merck Sharp & Dohme LLC | $89.07 | 5 | $0 (2024) |
| Cumberland Pharmaceuticals, Inc. | $82.39 | 2 | $0 (2023) |
| Paratek Pharmaceuticals, Inc. | $78.24 | 4 | $0 (2024) |
| La Jolla Pharmaceutical Company | $56.74 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $654.93 | 24 | AIMMUNE THERAPEUTICS, INC. ($146.91) |
| 2023 | $752.51 | 30 | Gilead Sciences, Inc. ($207.10) |
| 2022 | $360.14 | 14 | Janssen Products, LP ($99.00) |
| 2021 | $357.11 | 9 | ViiV Healthcare Company ($221.27) |
All Payment Transactions
77 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $26.02 | General |
| Category: Infections and Infectious Diseases | ||||||
| 11/14/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug), RECARBRIO, ZERBAXA | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/29/2024 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $25.01 | General |
| Category: Infections and Infectious Diseases | ||||||
| 10/08/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $31.92 | General |
| 10/01/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $26.13 | General |
| Category: VIROLOGY | ||||||
| 09/25/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $21.42 | General |
| Category: HIV | ||||||
| 08/29/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $32.14 | General |
| Category: VIROLOGY | ||||||
| 08/14/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $34.26 | General |
| 08/13/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $97.39 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 07/31/2024 | Ferring Pharmaceuticals Inc. | REBYOTA (Biological) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/26/2024 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $18.22 | General |
| Category: Infections and Infectious Diseases | ||||||
| 06/19/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $32.00 | General |
| Category: VIROLOGY | ||||||
| 05/23/2024 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $26.85 | General |
| Category: Infections and Infectious Diseases | ||||||
| 05/09/2024 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $1.02 | General |
| Category: ANTI-INFECTIVE | ||||||
| 05/08/2024 | ABBVIE INC. | DALVANCE (Drug), AVYCAZ, TEFLARO | Food and Beverage | In-kind items and services | $21.57 | General |
| Category: ANTI-INFECTIVE | ||||||
| 05/07/2024 | Melinta Therapeutics, LLC | Rezzayo (Drug), Kimyrsa, Orbactiv | Food and Beverage | In-kind items and services | $25.81 | General |
| Category: ANTIFUNGALS | ||||||
| 05/02/2024 | AIMMUNE THERAPEUTICS, INC. | VOWST (Biological) | Food and Beverage | In-kind items and services | $24.76 | General |
| Category: GI | ||||||
| 05/02/2024 | AIMMUNE THERAPEUTICS, INC. | VOWST (Biological) | Food and Beverage | In-kind items and services | $24.76 | General |
| Category: GI | ||||||
| 04/25/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: ANTIBIOTIC | ||||||
| 04/23/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $34.98 | General |
| 04/03/2024 | La Jolla Pharmaceutical Company | XACDURO (Drug) | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 02/28/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $29.00 | General |
| 02/27/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $34.23 | General |
| Category: HIV | ||||||
| 02/22/2024 | ABBVIE INC. | TEFLARO (Drug), DALVANCE, AVYCAZ | Food and Beverage | In-kind items and services | $19.93 | General |
| Category: ANTI-INFECTIVE | ||||||
| 12/07/2023 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $25.78 | General |
| Category: VIROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 60 | 104 | $20,876 | $5,544 |
| 2022 | 3 | 89 | 159 | $31,609 | $7,526 |
| 2021 | 2 | 39 | 64 | $13,412 | $3,459 |
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 24 | 48 | $10,704 | $2,885 | 26.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 20 | 33 | $6,699 | $1,681 | 25.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 16 | 23 | $3,473 | $978.65 | 28.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 54 | 106 | $21,518 | $4,941 | 23.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 19 | 29 | $6,467 | $1,616 | 25.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 16 | 24 | $3,624 | $968.71 | 26.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 24 | 43 | $8,729 | $2,065 | 23.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 15 | 21 | $4,683 | $1,393 | 29.7% |
About Anna Leviere
Anna Leviere is a Physician Assistant healthcare provider based in Lillington, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/20/2020. The National Provider Identifier (NPI) number assigned to this provider is 1093335044.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Anna Leviere has received a total of $2,125 in payments from pharmaceutical and medical device companies, with $654.93 received in 2024. These payments were reported across 77 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($1,927).
As a Medicare-enrolled provider, Leviere has provided services to 188 Medicare beneficiaries, totaling 327 services with total Medicare billing of $16,528. Data is available for 3 years (2021–2023), covering 8 distinct procedure/service records.
Practice Information
- Specialty Physician Assistant
- Other Specialties Student in an Organized Health Care Education/Training Program
- Location Lillington, NC
- Active Since 04/20/2020
- Last Updated 03/26/2021
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1093335044
Products in Payments
- DOVATO (Drug) $255.50
- Fetroja (Drug) $237.01
- SYMTUZA (Drug) $220.48
- MAVYRET (Drug) $170.72
- ZENPEP (Drug) $97.39
- CABENUVA (Biological) $84.78
- VIBATIV (Drug) $82.39
- NUZYRA (Drug) $78.24
- RUKOBIA (Drug) $65.43
- TEFLARO (Drug) $63.87
- Veklury (Drug) $63.40
- DALVANCE (Drug) $59.74
- PIFELTRO (Drug) $51.92
- VOWST (Biological) $49.52
- XERAVA (Drug) $40.97
- AVYCAZ (Drug) $37.40
- DIFICID (Drug) $37.15
- Rezzayo (Drug) $25.81
- Kimyrsa (Drug) $20.29
- Heplisav-B (Drug) $18.66
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Lillington
Bianca Goo, Pa-C, PA-C
Physician Assistant — Payments: $8,376
Neema Dave, Pa-C, PA-C
Physician Assistant — Payments: $4,451
David Paulson, Pa-C, PA-C
Physician Assistant — Payments: $4,306
Brandy Mountcastle, Pa-C, PA-C
Physician Assistant — Payments: $2,977
Maggie Jones
Physician Assistant — Payments: $2,348
Sara Moody
Physician Assistant — Payments: $2,233